Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-24 @ 3:31 PM
NCT ID:
NCT00496392
Eligibility Criteria:
Inclusion Criteria:
* Adult in- or out patient with cancer and breakthrough pain; using a stable, chronic opioid treatment for background pain.
* Minimum three BTP episodes per week and maximum four per day. Life expectancy of at least three months.
* Chemotherapy and palliative radiotherapy (except facial radiotherapy) are allowed.
* Randomisation in previous studies with NF, i.e. FT-016-IM, FT-017-IM or FT-018-IM, is not allowed.
* Previous use of Actiq is accepted.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00496392
Study Brief:
Protocol Section:
NCT00496392